Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: The most widely studied type of PSMA based PET/CT is 68Ga-labeled on the small molecular inhibitor PSMA-11 (also known as PSMAHBED-CC). Objectives: To assess the diagnostic value of 68Ga-PSMAPET/CT in prostatic cancer patients referred for initial assessment and post therapeutic follow–up after prostatectomy+/- receiving adjuvant therapy